Table 1 Characteristics of the patients
Variable | n = 119 (100%) |
|---|---|
Demographics | |
Age (years) | 68.6 ± 9.0 |
Sex, male | 65 (54.6) |
BMI (kg/m2) | 23.4 ± 4.1 |
Never smoker | 54 (45.4) |
Pulmonary Function Tests | |
FVC %predicted (%) | 84.3 ± 22.1 |
FEV1/FVC (%) | 79.6 ± 15.2 |
FEV1%predicted (%) | 91.0 ± 20.4 |
DLCO %predicted (%) | 76.2 ± 20.7 |
Procedural Details | |
Procedural time (min) | 38.5 ± 8.6 |
Fentanyl (µg) | 92.4 ± 14.0 |
Fentanyl (µg/kg/h) | 2.58 ± 0.88 |
Midazolam (mg) | 11.8 ± 4.9 |
Midazolam (mg/kg/h) | 0.32 ± 0.14 |
Number of biopsies | 2.3 ± 0.9 |
Number of biopsies per 30 min | 1.9 ± 0.9 |
Biopsy from upper lobes | 38 (31.9) |
Complications | |
Pneumothorax small | 1 (0.8) |
large | 1 (0.8) |
Bleeding mild | 82 (68.9) |
moderate | 26 (21.8) |
severe | 5 (4.2) |
Significant bleeding | 31 (26.1) |
Respiratory tract infection | 3 (2.5) |
90-day mortality | 0 (0.0) |
Histopathological Findings | |
Alveolar tissue obtained | 116 (97.5) |
Pathological diagnosis achieved | 97 (81.5) |